| Issue Date | Title | Author(s) |
| 13-Sep-2017 | A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation. | McLean, AR; Adlen, EK; Cardis, E; Elliott, A; Goodhead, DT, et al |
| 11-Oct-2011 | Adjuvant Chemotherapy in Older Women (ACTION) Study – What did we learn from the Pilot Phase? | Leonard R,; Ballinger, R; Cameron, D; Ellis, P; Fallowfield, LJ, et al |
| 3-May-2018 | Extracting DNA from FFPE Tissue Biospecimens Using User-Friendly Automated Technology: Is There an Impact on Yield or Quality? | Mathieson, W; Guljar, N; Sanchez, I; Sroya, M; Thomas, GA, et al |
| 1-Aug-2017 | GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial | Leonard, RCF; Adamson, DJA; Bertelli, G; Mansi, J; Yellowlees, A, et al |
| Mar-2022 | Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations | Balachandar, S; Graves, TJ; Shimonty, A; Kerr, K; Kilner, J, et al |
| 18-Jan-2017 | Meeting report: the 5th International expert symposium in Fukushima on radiation and health | Saenko, VA; Thomas, GA; Yamashita, S; |
| 14-May-2021 | Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident | Morton, LM; Karyadi, DM; Stewart, C; Bogdanova, TI; Dawson, ET, et al |
| 22-Jul-2020 | Why formalin-fixed, paraffin-embedded biospecimens must be used in genomic medicine: an evidence-based review and conclusion. | Mathieson, W; Thomas, GA; |